Financials

  • Market Capitalization 113.11 M
  • Employee 118
  • Founded 2010
  • CEO N/A
  • Website www.cibus.com
  • Headquarter Delaware, United States
  • FIGI BBG00H1CJS11
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.63
Rapporto prezzo/fatturato
21.88

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3806
ENGN
enGene Therapeutics Inc. - Common Stock
1.69 USD-2.31%-9.63%-6.11%-79.88%113.26 M USD
3812
INO
Inovio Pharmaceuticals, Inc. - Common Stock
1.11 USD-3.48%-3.48%-10.48%-57.14%114.77 M USD
3814
UNCY
Unicycive Therapeutics, Inc. - Common Stock
4.05 USD-1.46%-3.34%-23.15%-37.79%112.81 M USD
3817
HUMA
Humacyte, Inc. - Common Stock
0.39 USD-4.88%-22.00%-29.09%-75.63%108.34 M USD

Notizie